1Shepherd J,Cobbe SM,Ford I,et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J].N Engl J Med,1995,333(20):1301-1307.
2Grundy SM,Cleeman JI,Merz CN,et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ Guidelines[J].Circulation,2004,110(2):227-239.
3Knopp RH.Drug treatment of lipid disorders[J].N Engl J Med,1999,341(7):498-511.
4Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis:a randomized controlled trial[J].JAMA,2004,291 (9):1071-1080.
5Cannon CP,Braunwald E,MCCabe CH,et al.Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N Engl J Med,2004,350(15):1495-1504.
2GRUNDY S M,CLEEMAN J I,MERZ C N B,et al.Implications of recent clinical trials for the national cholesterol education program adult treatment panel Ⅲ guidelines[J].Circulation,2004,110(2):227-239.
3THOMAS A P,IRENE L,HENRY C,et al.The lipid treatment assessment project (L TAP) a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid lowering therapy and achieving low density lipoprotein cholesterol goals[J].Arch Intern Med,2000,160(4):459-467.
4LAW M R,WALD N J,RUDNICKA A R.Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease,and stroke: systematic review and meta analysis[J].BMJ,2003,326(7404):1423-1429.
5PASTERNAK R C,SMITH S C,BAIREY MERZ C N,et al.ACC/AHA/NHLBI clinical advisory on the use and safety of statins[J].Circulation,2002,106(8):1024-1028.
6SEVER P S,DAHLOF B,POULTER N R,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT LLA): a multicentre randomised controlled trial[J].Lancet,2003,361(9364):1149-1158.
7NISSEN S E,TUZCU E M,SCHOENHAGEN P,et al.Effect of intensive compared with moderate lipid lowering therapy on progression of coronary atherosclerosis[J].JAMA,2004,291(9):1071-1080.
8CANNON C P,BRAUNWALD E,McCABE C H,et al.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N Engl J Med,2004,350(15):1495-1504.
9candinavian Simvastatin Survival Study Group.Randomised trial of cholesterol lowering in 4444 subjects with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S)[J].Lancet,1994,344(8934):1383-1389.
10The long term intervention with pravastatin in ischemic disease (LIPID) sStudy Group.Prevention of cardiovascular events and death with pracastatin in patients with coronary heart disease and a broud range of initial cholesterol levels[J].N Engl J Med,1998,339(5):1349-1357.
